Medicare Enrolled

Dr. Allyson Harroff, M.D.

Medical Oncology · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2130 N.E.LOOP 410, San Antonio, TX 78217
2106567177
In practice since 2007 (19 years)
NPI: 1538291380 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Harroff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harroff? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Harroff

Dr. Allyson Harroff is a medical oncology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Harroff performed 34,871 Medicare services across 2,052 unique beneficiaries.

Between the years covered by Open Payments, Dr. Harroff received a total of $1,512 from 17 pharmaceutical and/or device companies across 24 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Harroff is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 25% volume in TX $1,512 industry payments

Medicare Practice Summary

Medicare Utilization ↗
34,871
Medicare services
Top 25% in TX for medical oncology
2,052
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,835 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron sucrose injection (Venofer) 9,700 $0 $2
Contrast dye for imaging (iodine-based) 7,992 $0 $3
Anti-nausea injection (fosaprepitant) 6,750 $0 $5
Dexamethasone injection (steroid) 2,070 $0 $1
Denosumab injection (Prolia/Xgeva) 1,260 $18 $66
Injection, granisetron hydrochloride, 100 mcg 960 $0 $24
Anti-nausea injection (Aloxi/palonosetron) 680 $1 $114
Complete blood count (CBC) with differential 662 $8 $36
Office visit, established patient (20-29 min) 621 $60 $250
Blood draw (venipuncture) 616 $8 $20
Comprehensive metabolic blood panel 577 $10 $64
Flow cytometry, additional marker 317 $18 $180
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 312 $21 $157
Administration of chemotherapy into vein, 1 hour or less 263 $94 $707
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session 142 $269 $2,762
Carcinoembryonic antigen (cea) protein level 139 $18 $99
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev 119 $176 $700
Injection, zoledronic acid, 1 mg 119 $7 $431
Immunoglobulin level test 114 $9 $56
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 104 $46 $313
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 98 $54 $211
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 94 $20 $128
Injection, diphenhydramine hcl, up to 50 mg 86 $1 $7
Drug injection, under skin or into muscle 83 $10 $96
Measurement of immunoglobulin light chains 80 $17 $60
Ct scan of chest with contrast 75 $47 $821
Administration of additional new drug or substance into vein, 1 hour or less 74 $49 $344
Ferritin level test (iron stores) 65 $13 $60
Iron level test 65 $6 $27
Iron binding capacity test 65 $9 $35
CT scan of abdomen and pelvis with contrast 61 $164 $1,067
Infusion, normal saline solution , 1000 cc 52 $2 $19
Microscopic examination for white blood cells with manual cell count 45 $4 $22
Complete blood count (CBC), automated 45 $6 $34
Prothrombin time test (blood clotting) 44 $4 $30
Office visit, established patient (30-39 min) 43 $96 $368
Infusion into a vein for hydration, each additional hour 37 $10 $75
Lactate dehydrogenase (enzyme) level 36 $6 $31
Reticulated (young) platelet measurement 35 $35 $143
New patient office visit, complex (60-74 min) 32 $164 $709
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 30 $89 $657
Nuclear medicine study from skull base to mid-thigh with ct scan 28 $1,099 $4,802
Thyroid stimulating hormone (TSH) test 27 $16 $80
New patient office visit (45-59 min) 24 $101 $565
Protein measurement, serum 18 $11 $99
Flow cytometry technique for dna or cell analysis, first marker 12 $56 $298
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
87.0% medium
11.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,512
Total received (2018-2024)
Avg $216/year across 7 years
Bottom 34% in TX for medical oncology
17
Companies
24
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,473 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$39 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$382
2023
$281
2022
$353
2021
$12
2020
$126
2019
$244
2018
$114

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$216
Gilead Sciences, Inc.
$145
EMD Serono, Inc.
$126
Genmab U.S., Inc.
$125
Bayer Healthcare Pharmaceuticals Inc.
$125
G1 Therapeutics, Inc.
$125
Janssen Biotech, Inc.
$125
Merck Sharp & Dohme LLC
$112
Amgen Inc.
$109
Incyte Corporation
$100
Lilly USA, LLC
$73
Novartis Pharmaceuticals Corporation
$60
Regeneron Healthcare Solutions, Inc.
$17
Tactile Systems Technology Inc
$16
AstraZeneca Pharmaceuticals LP
$14
Merck Sharp & Dohme Corporation
$14
Clovis Oncology, Inc.
$10
Top 3 companies account for 32.2% of total payments
Associated products mentioned in payments ›
Bavencio · COSELA · DARZALEX · ENHERTU · EXKIVITY · Epkinly · FRUZAQLA · Flexitouch Plus · KEYTRUDA · LIBTAYO · LYNPARZA · Nubeqa · RETEVMO · Rubraca · SCEMBLIX · TASIGNA · Trodelvy · Vectibix
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $4 per 100 Medicare services performed
Looking for a medical oncology specialist in San Antonio?
Compare medical oncologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
37
Per 100K population
1.8
County median income
$70,571
Nearest hospital
BAPTIST NEIGHBORHOOD HOSPITAL THOUSAND OAKS
4.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Harroff is a mixed practice specialist, with above-average Medicare volume (top 25% in TX), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Harroff experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Harroff performed 9,700 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harroff receive payments from pharmaceutical companies?
Yes. Dr. Harroff received a total of $1,512 from 17 companies across 24 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harroff's costs compare to other medical oncologists in San Antonio?
Dr. Harroff's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harroff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →